Smartphone-Based Neurobehavioral Assessments as a Diagnostic Aid in Autism
ConditionAutism Spectrum Disorder
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age3-12
SponsorBlinklab Limited
About this trial
Retrospective case-control study to assess the diagnostic accuracy in autism spectrum disorder (ASD) of a new smartphone-based platform designed to conduct neurometric evaluations by measuring facial and behavioural reflexes.
Eligibility criteria
Qualifiers
Male or female individuals between the ages of 3 - 12 years old at the time of consent.
Caregiver must be able to read, understand and sign the Informed Consent Form (ICF).
Normal or corrected-to-normal vision with visual acuity sufficient to watch short videos.
Hearing adequate to hear the auditory stimuli delivered via headphones.
Disqualifiers
Participants under 3 or over 12 years old.
Severe hearing or visual impairment.
Participants using medication that affects the nervous system (classified as ATC N0 medication, https://www.whocc.no).
Trial design
Treatments tested in this trial
- Blinklab diagnostic device
Treatment groups
450 Participants
are divided into 1 treatment groupSponsors and collaborators
Blinklab Limited
Lead sponsor
Mohammed VI National Center for the Disabled, Salé, Morocco
Collaborator
Source ClinicalTrials.gov